Work

Abstract C055: Incidence of gastrointestinal adverse events in advanced or metastatic cancer patients treated with Datopotamab Deruxtecan: A meta-analysis of phase III randomized controlled trials

Year: 2025

Type: review

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-c055

Authors: Ramaditya Srinivasmurthy, Jason Ta, Daniel T. Jones, Abbas Hussain, Riccesha Hattin, Rishi K. Nanda, Kyaw Z. Thein

Institutions: Icahn School of Medicine at Mount Sinai, University of South Florida, HCA Healthcare, University of Nevada, Las Vegas, Touro University Nevada, Comprehensive Cancer Centers of Nevada

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7093302524

FWCI:

Cites:

Cited by:

Related to: